Healthcare provider profile · identity verified

Megan Moyle Alexander, MD

Internal Medicine · WINSTON SALEM, NC · NPI 1467438739

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	96
Amlodipine Besylate	Amlodipine Besylate	288	70
Levothyroxine Sodium	Levothyroxine Sodium	227	54
Rosuvastatin Calcium	Rosuvastatin Calcium	193	56
Omeprazole	Omeprazole	181	53
Losartan Potassium	Losartan Potassium	179	51
Hydrochlorothiazide	Hydrochlorothiazide	178	45
Sertraline Hcl	Sertraline Hcl	162	42
Celecoxib	Celecoxib	161	47
Metoprolol Succinate	Metoprolol Succinate	146	44
Gabapentin	Gabapentin	126	39
Lisinopril	Lisinopril	120	35
Pantoprazole Sodium	Pantoprazole Sodium	103	31
Metformin Hcl Er	Metformin Hcl	102	30
Ozempic	Semaglutide	91	15
Diclofenac Sodium	Diclofenac Sodium	86	20
Tramadol Hcl	Tramadol Hcl	85	23
Bupropion Xl	Bupropion Hcl	82	23
Furosemide	Furosemide	79	26
Pravastatin Sodium	Pravastatin Sodium	77	22
Escitalopram Oxalate	Escitalopram Oxalate	74	16
Alendronate Sodium	Alendronate Sodium	71	20
Trazodone Hcl	Trazodone Hcl	69	20
Paroxetine Hcl	Paroxetine Hcl	67	18
Buspirone Hcl	Buspirone Hcl	59	15
Famotidine	Famotidine	59	17
Synthroid	Levothyroxine Sodium	58	13
Albuterol Sulfate Hfa	Albuterol Sulfate	56	28
Prednisone	Prednisone	56	47
Alprazolam	Alprazolam	55	23
Montelukast Sodium	Montelukast Sodium	54	17
Spironolactone	Spironolactone	53	14
Lorazepam	Lorazepam	49	19
Pregabalin	Pregabalin	48	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	17
Tamsulosin Hcl	Tamsulosin Hcl	47	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	25
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	46	suppressed
Carvedilol	Carvedilol	45	14
Duloxetine Hcl	Duloxetine Hcl	44	11
Fluticasone Propionate	Fluticasone Propionate	44	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	29
Meloxicam	Meloxicam	35	15
Clonazepam	Clonazepam	34	14
Glipizide Er	Glipizide	33	suppressed
Valsartan	Valsartan	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Simvastatin	Simvastatin	32	suppressed
Valacyclovir	Valacyclovir Hcl	31	13
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	28
Estradiol	Estradiol	28	13
Metformin Hcl	Metformin Hcl	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Mirtazapine	Mirtazapine	27	11
Atenolol	Atenolol	26	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Irbesartan	Irbesartan	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Repatha Sureclick	Evolocumab	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Nystatin	Nystatin	18	12
Rybelsus	Semaglutide	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	11
Eliquis	Apixaban	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Diazepam	Diazepam	16	12
Donepezil Hcl	Donepezil Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Trulicity	Dulaglutide	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Finasteride	Finasteride	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cefdinir	Cefdinir	12	12
Cephalexin	Cephalexin	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error